Connecticut Loses It with Companies Selling “Research Grade” GLP-1 Drugs

Cozen O'Connor
Contact
LinkedIn
Facebook
X
Send
Embed

Cozen O'Connor

  • Connecticut AG William Tong announced enforcement actions against companies that allegedly advertised, distributed, or sold so-called “research grade” versions of GLP-1 weight loss drugs in violation of state consumer protection laws.
  • The AG sued Triggered Brand for allegedly marketing and selling “research grade” versions of GLP-1 drugs that do not have FDA approval for human use, and issued a Civil Investigative Demand to Made in China, a Chinese international trade platform, over its alleged marketing and sale of “research grade” versions of GLP-1 drugs and the factories that manufacture them.
  • The AG also sent letters to weight loss clinics, med spas, and medical practices warning that the FDA has health and safety concerns associated with compounded versions of GLP-1 drugs and that continued marketing and sale may violated state consumer protection laws.
  • Other efforts to protect consumers from non-FDA approved versions of GLP-1 drugs include a letter sent by the National Association of Attorneys General requesting that the FDA take action to protect consumers from counterfeit forms of GLP-1 drugs.
Send Print Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.

© Cozen O'Connor

Written by:

Cozen O'Connor
Cozen O'Connor
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Cozen O'Connor on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign Up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide